Mingzhao Zhu

Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B

Wenjun Wang, Xiaoxiao Zhou, Yingjie Bian et al. · Nature Nanotechnology · 2020 · 226 citations · Full text

Nanoparticles, Nanomedicine, Cross-protection +15

H2A.Z facilitates licensing and activation of early replication origins

Haizhen Long, Liwei Zhang, Mengjie Lv et al. · Nature · 2019 · 180 citations

Transcriptional Regulation, Genetics, Early Replication Origins +4

NF-κB2 is required for the establishment of central tolerance through an Aire-dependent pathway

Mingzhao Zhu, Robert Chin, Peter A. Christiansen et al. · Journal of Clinical Investigation · 2006 · 129 citations · Full text

Immune Tolerance, Immunology, Immunologic Mechanism +23

Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion

Xiaojuan Liu, Longchao Liu, Zhenhua Ren et al. · Cell Reports · 2018 · 119 citations · Full text

Immunology, Immunotherapeutics, Innate Immunity +18

Ferritin nanoparticle-based SpyTag/SpyCatcher-enabled click vaccine for tumor immunotherapy

Wenjun Wang, Zhida Liu, Xiaoxiao Zhou et al. · Nanomedicine Nanotechnology Biology and Medicine · 2018 · 116 citations

Vaccination, Nanomedicine, Cross-protection +8